Results 131 to 140 of about 32,721 (222)

Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the Americas. [PDF]

Vaccines (Basel)
Mathur G, Domachowske JB, Graña MG, Ladak R, Langley JM, Olaiya O, Pompeo A, Taddei L, Villena R.   +8 more
europepmc   +1 more source

Meningococcal disease Unknown serogroup: (Week 33) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 19, 2023

Meningococcal disease, Unknown serogroup cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Meningococcal disease All serogroups: (Week 17) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 29, 2023

Meningococcal disease, All serogroups cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Invasive Meningococcal Disease-Changes in Epidemiologic Trends and Outcome over 24 Years in a Tertiary Care Hospital from Romania. [PDF]

Pathogens
Vișan CA, Norocea M, Neniu ME, Bilașco A, Vasile M, Vișan DE, Tudor AI, Drăgănescu AC, Tudor AM.   +8 more
europepmc   +1 more source

Meningococcal disease Serogroups ACWY: (Week 15) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 15, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Meningococcal disease, Serogroups ACWY cases.

core  

Meningococcal disease Serogroup B: (Week 16) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 22, 2023

Meningococcal disease, Serogroup B cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention. [PDF]

Hum Vaccin Immunother
Andani A, Abbing-Karahagopian V, Kavaliauskaite J, Schaffner TO, Sohn WY, Graña MG, Marshall H, Martinon-Torres F, Bonanni P, Rappuoli R, Taha MK.   +10 more
europepmc   +1 more source

Meningococcal disease Serogroup B: (Week 50) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 16, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Meningococcal disease, Serogroup B cases. The Weekly data are considered provisional and collected locally due to state,

core  

Meningococcal disease Unknown serogroup: (Week 45) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 11, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Meningococcal disease, Unknown serogroup cases. The Weekly data are considered provisional and collected locally due to

core  

Healthcare costs of invasive meningococcal disease: a nationwide population-based study using an innovative clustering method to identify sequelae. [PDF]

BMC Infect Dis
Duval X, Collin C, Baloche A, Fanchon L, Nora T, Hoen B.   +5 more
europepmc   +1 more source